Digg It
#1 in Business Subscribe Email Print

You are here: Home > Finance > Bankruptcy > Rationalising the Stigma of Bankruptcy Part 1

Tags

  • packaged
  • which
  • device
  • combination products
  • companies involved

  • Links

  • Options Education: Financing the Calendar!
  • Why is it that a Baby Handprint Picture Might be Right for You?
  • Investing Tips for Beginners
  • Digg It - Rationalising the Stigma of Bankruptcy Part 1

    In the first of a series of articles, Stephen Morgan tries to wrestle with the oft misunderstood lending criteria that Modern Day Financial Institutions use to he
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    lp fuel their financial expansion and growth but at what expense?

    Hardly a month seems to go by when the Media isn’t reporting some incidence of the suicide or a
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ttempted suicide of some individual who has taken the unfortunate decision that death seems preferable to having to come to terms with dealing with steadily amass
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ng debts.

    Now perhaps I am alone in this (I hope I am not) but there is something rather repugnant about a Society that tolerates the instance of someone choosin
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    g death rather than come to terms with the unfortunate situation they find themselves in.

    In the latest story, the case involved a young man who found himself th
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    recipient of threats of debt collection agencies calling on behalf of a high street Bank in the United Kingdom who quite frankly should have known better.

    The a
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    mount involved was roughly the equivalent of ?1500 ($2200) and the lender had apparently reviewed his case and decided that enough was enough and would be calling
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    in the amount and the account had to be settled.

    ENOUGH was ENOUGH!

    The world has gone crazy! Now I l know that all debts have to be paid and I quite accept th
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    at fact otherwise we risk the entire Western Economy and the whole principle of the free market economy and Capitalism going “down the spout” if these are not met
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    but sometimes a little dose of reality has to enter into the equation.

    Let me expand upon this concept. I love me nephew, I think he is great and would take up a
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    rms against anyone who thought otherwise. However I would not entertain the idea of him being financially responsible to take up a leading role with one of the We
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    stern Economy’s Central Banks.

    I’ll give him ?20 ‘cos he’s my nephew but lend him ?3,500 plus an unsecured credit card no way!

    That however is not the considere
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    opinion of one of the United Kingdoms leading High Street Banks who gaily have handed over banking facilities plus Credit Card to a Student who has all the track
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    record of an alcoholic who’s just been handed the key to a brewery!

    God knows how they managed to credit score this one. I know the facts and I am sure that I a
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    in position of facts that the bank aren’t but it does beg the question with some of today’s banking officials?

    Should their mothers let them out in the morning
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    without supervision?

    The sad result is that they are obviously buying market share. The stock answer is that a certain percentage of students are going on to bec
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    me “Captains of Industry” and will earn the opportunistic banks on the way a fortune – those who bankrolled them “in the early days will always be rewarded” etc b
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ut what about those who don’t become the “Captains of Tomorrow’s Industry”? do they become the collateral damage of today’s “Financial War of Attrition”?

    Does th
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    rising trend of bankruptcies amongst the “twenty-something’s”, the post student generation not tell them something?

    Isn’t it about time that that someone tries
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    to tell them that a little fiscal prudence early on might actually help them make more substantial and moral profits later on?

    “Hello……is there anyone out there?


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/90928/diggit-Rationalising-the-Stigma-of-Bankruptcy-Part-1.html">Rationalising the Stigma of Bankruptcy Part 1</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/90928/diggit-Rationalising-the-Stigma-of-Bankruptcy-Part-1.html]Rationalising the Stigma of Bankruptcy Part 1[/url]

    Related Articles:

    Defining the Marketing Niche

    How to Use IMAGES With Your Keyword or Keyword Phrase - SEO Tactics

    Save Big By Being Patient

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com